РусскийEnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Nefedov А.A., Mamchur V.I., Larionov V.B., Dronov S.M.

    COMPUTER SIMULATION OF COOPERATIVE ACTION OF CITICOLINE WITH METHYL-PREDNISOLONE PHARMACOTHERAPY IN MULTIPLE SCLEROSIS


    About the author: Nefedov А.A., Mamchur V.I., Larionov V.B., Dronov S.M.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation Combined use of physiologically active compounds directed at optimizing their joint of pharmacotherapeutic effect. However, the successful use of combined dosage forms may be limited by the interaction of their constituents on physico-chemical, pharmaceutical and biological levels (pharmacological interaction) and requires a preliminary assessment of possible interactions and potential compatibility of certain pharmaceutical ingredients. We analyzed the results of their research, reflecting the comparative description of the impact of facilities of neuroprotective, antioxidant complex in neurological status, conditioned reflex activity, behavioral reactions of rats processes of energy and functional state of mitochondria of neurons in the cerebral cortex and histomorphometrical allowing the entities under the experimental equivalent multiple sclerosis. It is shown that the combined use of citicoline and methylprednisolone strongly reduces the severity of neurological disorders compared to the group receiving hormone therapy base. Analysis of the acid-alkaline properties was conducted using ACD / pKa DB. The molecular weight, solubility, hydrophobicity determined additive methods using computer programs. The presented combination of "methylprednisolone, citicoline" no possible interactions both on physical and chemical level (in a combination dosage form) and the pharmacokinetic level stages. Also on the joint use of citicoline methylprednisolone expect strengthening its stimulating action. Based on the difference in half-life, and indirect (indirectly through metabolic processes) mechanism of the therapeutic effect of the compounds examined, with pharmacokinetic standpoint of methylprednisolone combination of citicoline is safe and effective.
    Tags multiple sclerosis, pharmacotherapy, pharmacokinetics, computer simulation
    Bibliography
    • Belenichev I.F. Ratsionalnaya neyroprotektsiya / I.F. Belenichev, V.I. Cherniy, Yu.M. Kolesnik [i dr.] // – Donetsk: izd. Zaslavskiy A.Yu., -2009. – 262 s.
    • Golovenko N.Ya. Fiziko-himicheskaya farmakologiya / N.Ya. Golovenko // - Odessa, Astroprint. – 2004. – 720 s.
    • Yevtushenko S.K. Sovremennyie podhodyi k lecheniyu rasseyannogo skleroza (II soobschenie)/ S.K. Yevtushenko, I.N. Derevyanko // Mezhdunarodnyiy nevrologicheskiy zhurnal. – 2006.– No. 2(6). – S. 70 – 85.
    • Zybina N. N. «Okislitelnyiy stress» pri rasseyannom skleroze / N.N. Zyibina, G.N. Bisaga, M.Yu. Frolova // Immunooposredovannyiy remitiruyuschiy rasseyannyiy skleroz. – SPb.: Roza mira, -2003. – S. 101 – 125.
    • Nefedov A. A. Opyt primeneniya tsitikolina v eksperimentalnoy terapii modelirovannogo allergicheskogo entsefalomielita / A.A. Nefedov, V.I. Mamchur // Visnik problem biologiyi i meditsini. – 2015. – Vip.2, T. 4 (121). – S. 165-170.
    • Nefyodov O.O. Analiz vplivu tsitikolinu na bezumovno-reflektornu aktivnist schuriv z eksperimentalnim alergichnim entsefalomielitom / O.O. Nefyodov // Hist. – 2015. – vip. 17. – S. 378.
    • Nefedov A. A. Vozmozhnosti farmakologicheskoy korrektsii kognitivnyih rasstroystv v usloviyah eksperimentalnogo ekvivalenta rasseyannogo skleroza / A.A. Nefedov, V.I. Mamchur // MedichnI perspektivi. – 2015. – T. HH, No. 2. – S. 4-11
    • Nefodov O.O. Zastosuvannya tsitikolinu yak sposib pidvischennya efektivnosti bazovoyi gormononalnoyi terapiyi rozsiyanogo sklerozu (eksperimentalne doslidzhennya): Informatsiyniy list. – Vip. 8 z problemi «FarmakologIya» / O.O. Nefodov, V.Y. Mamchur // – K. : UkrmedpatentInform, -2015. – 4 s.
    • Odinak M. M. Novyie podhodyi k antioksidantnoy terapii pri rasseyannom skleroze/ M.M. Odinak, G.N. Bisaga, I.V. Zarubina // Zhurn. nevrologii i psihiatrii. – 2002. – Spets. vyipusk «Rasseyannyiy skleroz». – S. 72 – 75.
    • Odinak M. M. Neyroprotektsiya pri rasseyannom skleroze / M.M. Odinak, G.N. Bisaga // Neyroimmunologiya. – 2005. – T. 3, No.2. – S. 105 – 106.
    • Hohlfeld R. Neuroprotection in multiple sclerosisт/ R. Hohlfeld, L. Kapposт // – Cambridge Med. Pub., -2004. – 54 p.
    • ACD/pKaDB http://www.whocc.no/atc_ddd_index/
    • Dissolution Methods, Food and Drug Administration http://www.accessdata. fda.gov/scripts/cder /dissolution/ dsp_SearchResults_Dissolutions.sfm?PrintAll=1/
    • DrugBank http://www.drugdfnk.ca/drugs/
    • PubChem substance http://pubchem.ncbi.nlm.nih.gov/
    Publication of the article «World of Medicine and Biology» №2(56), 2016 year, 052-058 pages, index UDK 615.214+615.357:004.001.57:616.832-004.2-092.9